Showing 1521-1530 of 23119 results for "".
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
https://reachmd.com/programs/project-oncology/monitoring-adverse-events-post-car-t-the-latest-approaches-and-best-practices/35453/This is a non-certified educational series produced and controlled by ReachMD. As CAR T-cell therapy advances, so does the complexity of adverse event monitoring. Due to evolving insights into acute toxicities, infections, cytopenias, and secondary malignancies, both inpatient and outpatient care moAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
https://reachmd.com/programs/frontlines-multiple-sclerosis/aging-and-multiple-sclerosis-insights-from-the-2024-cmsc-consensus-statement/32664/Tune in to hear two experts share their insights and takeaways from the Consortium of Multiple Sclerosis Centers’ 2024 Consensus Statement on MS and aging.DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-jj-boosts-dermatology-pipeline-new-humira-biosimilar-launched/24561/In this episode of DermwireTV, Johnson & Johnson makes a major acquisition to expand its dermatology treatment pipeline; the first high-concentration, citrate-free biosimilar to Humira is launched in the US; and in the C-Suite Chats feature, the CEO of Benev discusses the medical aesthetic markeInvestigating the Risk of Schizophrenia Among ADHD Patients with Psychiatric Comorbidities
https://reachmd.com/programs/neurofrontiers/investigating-the-risk-of-schizophrenia-among-adhd-patients-with-psychiatric-comorbidities/17868/Could psychiatric comorbidities with ADHD be associated with schizophrenia? Learn more about the potential connection.Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
https://reachmd.com/programs/project-oncology/early-breast-cancer-care-omitting-radiation-therapy-linked-to-less-fear-of-recurrence/16359/Read more to learn about the compelling evidence of EBC from the PROSPECT (ANZ-1002) study.APP Biosimilar Education Video Series Module 4
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/app-biosimilar-education-video-series-module-4/15969/This series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosiTips To Nurture Leads
https://modernaesthetics.com/topics/practice-development/tips-to-nurture-leads/35211/Grow your practice by converting leads to patients.Birth Rights & Wrongs: How Medicine & Technology Are Remaking Reproduction & the Law
https://reachmd.com/programs/book-club/birth-rights-wrongs-how-medicine-technology-are-remaking-reproduction-the-law/11001/Everything from medical and legal literature to social media is calling our attention to reproductive negligence. Here’s why.Special Health Considerations for Female Athletes
https://reachmd.com/programs/primary-care-today/special-health-considerations-for-female-athletes/7661/Dr. Brian McDonough welcomes Dr. Liz Joy, President-Elect of the American College of Sports Medicine, President of the Female Athlete Triad Coalition, and Adjunct Professor of Family & Community Health at the University of Utah School of Medicine. Their discussion centers on health maintenance fMeet Lee Freedman, MD
https://reachmd.com/programs/meet-the-host/meet-lee-freedman-md/7281/Get to know seasoned ReachMD host, Dr. Lee Freedman, from his perspectives on clinical practice to his areas of strongest interest in the medical broadcasting arena. Dr. Freedman shares his most memorable interviews, and his pursuits both in and out of the office setting.